Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
4.500
+0.380 (9.22%)
At close: Feb 21, 2025, 4:00 PM
4.190
-0.310 (-6.89%)
After-hours: Feb 21, 2025, 6:06 PM EST

RGC Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
Net Income
-4.3-5.87-7.45-1.35-0.81
Upgrade
Depreciation & Amortization
0.750.770.60.030.01
Upgrade
Loss (Gain) From Sale of Assets
-0---
Upgrade
Stock-Based Compensation
0.450.922.76--
Upgrade
Other Operating Activities
-0.31-0.28-0.16--
Upgrade
Change in Other Net Operating Assets
-0.59-0.51-1.020.550.08
Upgrade
Operating Cash Flow
-4-4.96-5.27-0.77-0.73
Upgrade
Capital Expenditures
-0.01-0.03-0.78--0.12
Upgrade
Sale of Property, Plant & Equipment
-0---
Upgrade
Investment in Securities
5.250.09-10--
Upgrade
Investing Cash Flow
5.240.06-10.78--0.12
Upgrade
Short-Term Debt Issued
---0.610.99
Upgrade
Total Debt Issued
---0.610.99
Upgrade
Short-Term Debt Repaid
---0.43--
Upgrade
Total Debt Repaid
---0.43--
Upgrade
Net Debt Issued (Repaid)
---0.430.610.99
Upgrade
Issuance of Common Stock
--22.67--
Upgrade
Other Financing Activities
0.10.130.16-0.17-
Upgrade
Financing Cash Flow
0.10.1322.410.440.99
Upgrade
Foreign Exchange Rate Adjustments
0.05-0.08---
Upgrade
Net Cash Flow
1.4-4.856.36-0.330.14
Upgrade
Free Cash Flow
-4.01-4.99-6.05-0.77-0.84
Upgrade
Free Cash Flow Per Share
-0.31-0.38-0.47-0.08-0.08
Upgrade
Levered Free Cash Flow
-1.88-2.28-2.69-0.28-0.52
Upgrade
Unlevered Free Cash Flow
-1.88-2.28-2.69-0.28-0.52
Upgrade
Change in Net Working Capital
0.130.030.51-0.55-0.1
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.